Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davinder Parsad

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Indian Journal of Dermatology, Venereology and Leprology|July 22, 2017
Cholinergic urticaria: Clinicoepidemiological paradigms from a tertiary care center in North IndiaMuthu Sendhil Kumaran, Amanjot Kaur Arora, Davinder Parsad
Dermatologic Therapy|October 30, 2020
Immune modulatory effects of lenalidomide on the cultured peripheral blood mononuclear cells from vitiligo patientsNaveed Pervaiz, Harjot Kaur, Davinder Parsad, et al.
Indian Journal of Dermatology, Venereology and Leprology|November 22, 2018
Everything is in the name: Macular hyperpigmentation of uncertain etiology or acquired dermal macular hyperpigmentation of varied etiologies?Anuradha Bishnoi, Keshavamurthy Vinay, Sendhil Muthu Kumaran, et al.
Journal of Cutaneous and Aesthetic Surgery|May 17, 2011
Proton pump inhibitor induced depigmentation in vitiligoAnantha Prasad Holla, Ravinder Kumar, Davinder Parsad, et al.
Archives of Dermatological Research|August 2, 2020
Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot studyAnuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, et al.
Pigment Cell & Melanoma Research|July 2, 2026
Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo TrialsHitaishi Mehta, Muthu Sendhil Kumaran, Davinder Parsad, et al.
Journal of Dermatological Science|October 11, 2020
Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathwayHitaishi Kaushik, Deepak Kaul, Muthu Sendhil Kumaran, et al.
International Journal of Dermatology|February 1, 2006
Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligoGeeta R Tegta, Davinder Parsad, Subroto Majumdar, et al.
The Breast Journal|March 9, 2018
Dermatofibrosarcoma protuberans-A rare lesion on breastAnuradha Bishnoi, Dipankar De, Davinder Parsad, et al.
Journal of Cutaneous and Aesthetic Surgery|May 17, 2011
Modified Procedure of Noncultured Epidermal Suspension Transplantation: Changes are the Core of Vitiligo SurgeryAnantha Prasad Holla, Ravinder Kumar, Davinder Parsad, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Indian Journal of Dermatology, Venereology and Leprology|July 22, 2017
Cholinergic urticaria: Clinicoepidemiological paradigms from a tertiary care center in North IndiaMuthu Sendhil Kumaran, Amanjot Kaur Arora, Davinder Parsad
Dermatologic Therapy|October 30, 2020
Immune modulatory effects of lenalidomide on the cultured peripheral blood mononuclear cells from vitiligo patientsNaveed Pervaiz, Harjot Kaur, Davinder Parsad, et al.
Indian Journal of Dermatology, Venereology and Leprology|November 22, 2018
Everything is in the name: Macular hyperpigmentation of uncertain etiology or acquired dermal macular hyperpigmentation of varied etiologies?Anuradha Bishnoi, Keshavamurthy Vinay, Sendhil Muthu Kumaran, et al.
Journal of Cutaneous and Aesthetic Surgery|May 17, 2011
Proton pump inhibitor induced depigmentation in vitiligoAnantha Prasad Holla, Ravinder Kumar, Davinder Parsad, et al.
Archives of Dermatological Research|August 2, 2020
Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot studyAnuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, et al.
Pigment Cell & Melanoma Research|July 2, 2026
Revisiting Stability: The Missing Therapeutic Endpoint in Active Vitiligo TrialsHitaishi Mehta, Muthu Sendhil Kumaran, Davinder Parsad, et al.
Journal of Dermatological Science|October 11, 2020
Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathwayHitaishi Kaushik, Deepak Kaul, Muthu Sendhil Kumaran, et al.
International Journal of Dermatology|February 1, 2006
Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligoGeeta R Tegta, Davinder Parsad, Subroto Majumdar, et al.
The Breast Journal|March 9, 2018
Dermatofibrosarcoma protuberans-A rare lesion on breastAnuradha Bishnoi, Dipankar De, Davinder Parsad, et al.
Journal of Cutaneous and Aesthetic Surgery|May 17, 2011
Modified Procedure of Noncultured Epidermal Suspension Transplantation: Changes are the Core of Vitiligo SurgeryAnantha Prasad Holla, Ravinder Kumar, Davinder Parsad, et al.
Pageof 21